Prime Medicine won a legal battle with Beam Therapeutics on Wednesday. Prime shares jumped while Beam stock skidded.
Yahoo
Skip to navigation
Skip to main content
Skip to right column
Gene Editors, Including Powerhouse Beam Therapeutics, Diverge On Legal Battle ·
Investor's Business Daily
